DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Ademetionine is an investigational drug.
There have been 5 clinical trials for Ademetionine. The most recent clinical trial was a Phase 3 trial, which was initiated on October 1st 2013.
The most common disease conditions in clinical trials are Liver Diseases, Cholestasis, and Drug-Induced Liver Injury, Chronic. The leading clinical trial sponsors are Beijing 302 Hospital, Zhejiang Hisun Pharmaceutical Co. Ltd., and Abbott.
There are two US patents protecting this investigational drug and seventeen international patents.
Recent Clinical Trials for Ademetionine
|36 Weeks Short-Term Optimization Treatment of Glucocorticosteroid in the Patients With Chronic Recurrent DILI||Beijing 302 Hospital||Phase 1/Phase 2|
|Efficacy and Safety of Glucocorticosteroid Treatment in the Patients With Chronic Recurrent DILI||Beijing 302 Hospital||Phase 1/Phase 2|
|Study With Heptral in Subjects With Liver Disease Due to Alcohol Consumption||Ascent||Phase 3|
Top disease conditions for Ademetionine
Top clinical trial sponsors for Ademetionine
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Ademetionine||Start Trial||Method and culture medium for improving pluripotent stem cell differentiation inducing efficiency||NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY (Kumamoto, JP)||Start Trial|
|Ademetionine||Start Trial||Therapeutic nuclease compositions and methods||University of Washington (Seattle, WA)||Start Trial|
|Ademetionine||Start Trial||Methods of expressing products in mammalian cells||INTREXON CEU, INC. (Blacksburg, VA)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Ademetionine||European Patent Office||2644694||2030-10-28||Start Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|